Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
The Cancer Center of Kansas (CCK) is a prominent physician-owned oncology and hematology practice headquartered in Wichita, Kansas. Founded in 1977, the center provides comprehensive cancer care across more than 20 locations throughout the state, specializing in medical oncology, hematology, and radiation oncology. CCK is distinguished by its extensive clinical research program, serving as a major site for Phase I through Phase III clinical trials in partnership with the National Cancer Institute (NCI) and various pharmaceutical developers. The organization is dedicated to providing advanced, university-level cancer treatment within a community setting, ensuring patient access to the latest therapeutic innovations and personalized care plans.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Cancer Center of Kansas.